Crohns & Colitis 360
Scope & Guideline
Exploring breakthroughs in Crohn's and colitis treatment.
Introduction
Aims and Scopes
- Clinical Management of IBD:
Research aimed at optimizing treatment pathways, medication adherence, and clinical decision-making in the management of Crohn's disease and ulcerative colitis. - Patient-Centric Research:
Studies focusing on patient experiences, perspectives, and quality of life related to IBD, emphasizing the importance of patient engagement in treatment decisions. - Innovative Therapeutics:
Exploration of new therapeutic agents, including biologics and small molecules, and their efficacy, safety, and long-term outcomes in IBD treatment. - Epidemiological and Health Economic Studies:
Research investigating the prevalence, healthcare costs, and economic burden of IBD, providing insights into the broader impact of these diseases on healthcare systems. - Use of Technology in IBD Management:
Utilization of artificial intelligence, machine learning, and telehealth to enhance diagnostic accuracy, treatment adherence, and patient monitoring. - Nutritional and Dietary Interventions:
Exploration of the role of diet and nutrition in managing IBD symptoms and improving patient outcomes, including the effectiveness of dietary therapies.
Trending and Emerging
- Real-World Evidence and Patient Outcomes:
There is a growing emphasis on real-world studies that assess treatment effectiveness and patient-reported outcomes, highlighting the importance of understanding therapy impacts in everyday clinical settings. - Telehealth and Remote Monitoring:
Research exploring telehealth solutions and remote patient monitoring technologies is on the rise, especially in the context of increasing patient needs for accessible care and management during the COVID-19 pandemic. - Psychosocial Factors in IBD:
Emerging studies focus on the psychosocial aspects of living with IBD, including the impact of mental health on disease management and the importance of addressing psychological comorbidities. - Diversity and Health Disparities:
There is an increasing awareness and study of racial, ethnic, and geographic disparities in IBD care and outcomes, emphasizing the need for equitable healthcare access. - Dietary Interventions and Personalized Nutrition:
Research into dietary therapies and their role in managing IBD symptoms is expanding, with a focus on personalized nutritional approaches tailored to individual patient needs.
Declining or Waning
- Traditional Pharmacotherapy:
Research focused exclusively on conventional medications for IBD, such as corticosteroids and thiopurines, seems to be declining as newer therapies gain attention. - Surgical Interventions:
The volume of studies addressing surgical management of IBD, including colectomies and resections, is decreasing, possibly due to a shift towards medical management and minimally invasive techniques. - Basic Science and Mechanistic Studies:
There is less emphasis on basic science research exploring the underlying mechanisms of IBD, as the journal increasingly prioritizes clinical and translational research. - Single-Center Studies:
The prevalence of single-center studies is diminishing in favor of multicenter collaborations that provide broader data and insights into IBD management. - Conventional Epidemiological Studies:
Traditional epidemiological research focusing solely on demographic trends in IBD without integrating patient-reported outcomes or economic evaluations appears to be less frequent.
Similar Journals
Gastroenterology Review-Przeglad Gastroenterologiczny
Transforming Gastroenterology Through Open Access ResearchGastroenterology Review-Przeglad Gastroenterologiczny is a premier, peer-reviewed journal published by TERMEDIA PUBLISHING HOUSE LTD, focusing on the dynamic field of gastroenterology. Since its inception in 2006, it has embraced an Open Access model, ensuring that the latest research is readily accessible to a global audience, fostering collaboration and innovation. Based in Poland, this journal serves as a crucial platform for disseminating significant findings in gastrointestinal research, with a current Scopus rank placing it at the 39th percentile in its category. With a commitment to advancing the understanding of gastroenterological conditions, *Gastroenterology Review* publishes original articles, reviews, and case studies that contribute to both clinical practice and academic research. The journal is particularly aimed at researchers, healthcare professionals, and students who ignite dialogues that shape the future of gastrointestinal health. Explore the comprehensive insights that this journal offers, as it encapsulates vital developments from 2008 to 2024 in the ever-evolving landscape of gastroenterology.
Journal of Crohns & Colitis
Elevating the discourse on Crohn's and colitis.Journal of Crohns & Colitis, published by Oxford University Press, is a premier academic platform dedicated to advancing research in the field of gastroenterology. With an impressive impact factor placing it in the Q1 quartile for both gastroenterology and miscellaneous medicine, this journal stands out as a vital resource for researchers, practitioners, and students interested in inflammatory bowel diseases, particularly Crohn's disease and ulcerative colitis. The journal has successfully converged academic discourse since its inception in 2007, consistently ranking among the top publications in its category, reflecting its reputation and influence within the scientific community. Located in the United Kingdom, the journal offers a platform for disseminating high-quality research and innovative clinical studies, thereby enhancing our understanding and management of gastrointestinal disorders. Researchers are encouraged to submit their findings to contribute to this pivotal dialogue in the field.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
Pioneering research for a healthier future.The EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, published by LIPPINCOTT WILLIAMS & WILKINS, serves as a key platform for disseminating cutting-edge research in the fields of gastroenterology and hepatology since its inception in 1989. With its ISSN 0954-691X and E-ISSN 1473-5687, the journal has established a prominent reputation, as reflected in its 2023 rankings, placing it in Q2 for Gastroenterology and Q3 for Hepatology. It is ranked #75 out of 167 in gastroenterology and #39 out of 82 in hepatology according to Scopus, highlighting its importance in advancing knowledge and clinical practices. While it does not currently offer open access options, the journal remains essential for researchers, healthcare professionals, and students seeking to stay abreast of significant developments and innovations in digestive health. By providing rigorous peer-reviewed articles, the EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY continues to contribute to the understanding and treatment of gastrointestinal and liver diseases, making it a vital resource in the medical community.
Gastroenterology Insights
Advancing the Frontiers of Digestive HealthGastroenterology Insights is a premier open-access journal published by MDPI since 2009, focusing on essential research and developments within the fields of gastroenterology and hepatology. With a dedicated ISSN of 2036-7414 and E-ISSN 2036-7422, this journal serves as a vital platform for disseminating innovative studies and insights pertinent to gastrointestinal health, disorders, and treatment modalities. Based in Switzerland, Gastroenterology Insights boasts a significant academic presence, currently positioned in the Q3 quartile for both gastroenterology and hepatology categories as of 2023, reflecting its impactful contributions to the disciplines. With Scopus rankings placing it at the 94th and 48th positions in gastroenterology and hepatology respectively, the journal is committed to advancing knowledge and fostering collaboration among researchers, professionals, and students alike. By providing an open-access model, it ensures that high-quality research is accessible globally, thereby enhancing the reach and impact of crucial findings in the science of digestive health. Researchers looking to publish cutting-edge work will find Gastroenterology Insights a valuable resource for both sharing and acquiring knowledge.
Clinical Gastroenterology and Hepatology
Innovating Insights for Digestive HealthClinical Gastroenterology and Hepatology, published by Elsevier Science Inc, stands as a leading journal in the fields of gastroenterology and hepatology. With an ISSN of 1542-3565 and an E-ISSN of 1542-7714, this esteemed publication has earned its place in the top quartile (Q1) of both gastroenterology and hepatology categories as of 2023, ranking 6th out of 167 and 7th out of 82 respectively. The journal aims to disseminate innovative research, clinical studies, and case reports that advance the understanding and treatment of gastrointestinal and liver diseases. Targeted towards researchers, healthcare professionals, and students, it provides crucial insights into emerging therapies and medical advancements. Clinical Gastroenterology and Hepatology is not only a pivotal resource for contemporary gastroenterological research but also fosters collaboration and knowledge-sharing within the medical community. With a converging publication history from 2003 to the present, the journal continues to build on its solid foundation of scientific excellence and relevance.
DISEASES OF THE COLON & RECTUM
Discovering Solutions for Colorectal ChallengesDISEASES OF THE COLON & RECTUM, published by Lippincott Williams & Wilkins, stands as a critical resource in the field of gastroenterology, focusing on the comprehensive study and management of colorectal diseases. With an ISSN of 0012-3706 and an E-ISSN of 1530-0358, this journal serves a diverse audience, including researchers, clinicians, and students interested in the latest advancements in this vital area of medicine. Recognized for its quality, it holds a Q2 ranking in both Gastroenterology and Miscellaneous Medicine categories for 2023 and is positioned at the 58th percentile within its Scopus rank. Since its inception in 1958, the journal has dedicated itself to disseminating original research, reviews, and clinical studies, providing a platform for sharing innovative findings that drive the field forward. While it is not an open access journal, its content remains pivotal for professionals looking to stay apprised of evidence-based practices and emerging trends in colorectal health. With ongoing contributions expected until 2024, DISEASES OF THE COLON & RECTUM continues to be an indispensable source of knowledge for anyone engaged in the intricacies of digestive health.
Frontline Gastroenterology
Championing Excellence in Gastroenterological ResearchFrontline Gastroenterology is a leading academic journal published by the BMJ Publishing Group that plays a vital role in advancing the field of gastroenterology and hepatology. Established in 2013, this prestigious journal has established itself as a significant resource for researchers, healthcare professionals, and students alike, maintaining a commendable impact factor and consistently achieving a Q2 ranking in both gastroenterology and hepatology categories as of 2023. With its focus on disseminating high-quality, peer-reviewed research, Frontline Gastroenterology covers a wide scope of topics pertinent to the understanding, diagnosis, and treatment of gastrointestinal and liver diseases. Although it does not offer Open Access options, its content is accessible through various institutional and personal subscriptions, ensuring that critical findings reach an international audience. As the journal continues to converge into the future, it remains dedicated to fostering innovation and dialogue in gastroenterological sciences.
JGH Open
Connecting Researchers, Transforming OutcomesJGH Open is a prominent open-access journal dedicated to advancing knowledge in the fields of Gastroenterology and Hepatology, published by WILEY. Since its inception in 2017, the journal has served as a crucial platform for researchers, professionals, and students to disseminate innovative research findings and clinical insights. With an impact factor and Scopus rankings reflecting its steady growth—ranking in the 3rd quartile for both Gastroenterology (Q3) and Hepatology (Q3)—JGH Open is positioned within the competitive landscape of medicine. Its commitment to open access enhances the visibility and accessibility of high-quality research, ensuring that significant advancements in understanding diseases of the gastrointestinal tract and liver reach a broad audience. With a focus on collaboration and dissemination of knowledge, JGH Open aims to contribute to the global discourse and improve outcomes in gastrointestinal health.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
Advancing pediatric health through nutrition and gastrointestinal research.Journal of Pediatric Gastroenterology and Nutrition is a premier academic journal published by Wiley, focusing on the critical intersection of pediatric gastroenterology and nutrition. Established in 1982, this journal has been at the forefront of research and clinical practices for over four decades and continues to contribute invaluable insights to the fields of pediatrics and gastrointestinal health, boasting a Q1 ranking in Pediatrics, Perinatology and Child Health and a Q2 ranking in Gastroenterology as of 2023. The journal features a comprehensive array of original research, review articles, and clinical studies aimed at improving the understanding and management of pediatric gastrointestinal disorders and nutrient imbalances. Edited with expertise, the Journal of Pediatric Gastroenterology and Nutrition serves as an essential resource for clinicians, researchers, and students dedicated to advancing the well-being of children with digestive health issues. Readers can access the journal's impactful research studies through traditional subscriptions.
PRACTICAL GASTROENTEROLOGY
Exploring Innovations in Gastrointestinal HealthPRACTICAL GASTROENTEROLOGY is a distinguished journal dedicated to the field of gastroenterology, published by Shugar Publishing Inc in the United States. With an ISSN of 0277-4208, the journal serves as a pivotal resource for medical professionals, researchers, and students keen on staying abreast of the latest advancements and practical applications in gastrointestinal health. Although it does not currently operate under an Open Access model, it has been a respected publication since its inception, spanning significant years of research from 1989 to 2013 and resuming again from 2016 to 2023. Despite holding a current Q4 ranking in Gastroenterology with Scopus, its commitment to quality insights provides a platform for critical information dissemination, making it an essential read for those engaged in clinical practice and academic research. The journal’s objectives include addressing practical challenges in gastroenterology, bridging the gap between research and clinical implementation, and fostering ongoing education among practitioners in this dynamic field.